Biochemistry Quiz: Pentose Phosphate Pathway

What this quiz covers

This quiz focuses on Pentose Phosphate Pathway, giving you a quick way to practice the rules, question types, and explanations that matter most for Biochemistry.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

Question 1

1. By running the oxidative phase of the PPP at a maximal rate to produce excess ribose-5-phosphate and NADPH.
2. By reversing the non-oxidative phase, converting glycolytic intermediates like fructose-6-phosphate into ribose-5-phosphate. (correct answer)
3. By exclusively using the nucleotide salvage pathway, thus bypassing the need for de novo synthesis from ribose-5-phosphate.
4. By activating glucose-6-phosphate dehydrogenase through phosphorylation, increasing its specific activity for ribose synthesis.

Explanation: When the need for ribose-5-phosphate for nucleotide synthesis outweighs the need for NADPH, cells can bypass the NADPH-producing oxidative phase. The non-oxidative phase is reversible and can utilize intermediates from glycolysis, such as fructose-6-phosphate and glyceraldehyde-3-phosphate, to synthesize ribose-5-phosphate. This allows for the production of pentoses without generating excess NADPH.

Question 2

1. A genetic defect causing overactivity of glucose-6-phosphate dehydrogenase.
2. Inhibition or deficiency of the enzyme 6-phosphogluconate dehydrogenase. (correct answer)
3. High flux through the non-oxidative pathway to meet a demand for glycolytic intermediates.
4. Allosteric inhibition of transketolase by high levels of erythrose-4-phosphate.

Explanation: 6-phosphogluconate dehydrogenase catalyzes the conversion of 6-phosphogluconate to ribulose-5-phosphate, producing NADPH. If this enzyme is inhibited or deficient, its substrate, 6-phosphogluconate, will accumulate. The low NADP⁺/NADPH ratio indicates that G6PD is active but the second oxidative step is blocked, trapping NADPH and preventing NADP⁺ regeneration at this step. This specific combination of findings points directly to a block at 6-phosphogluconate dehydrogenase.

Question 3

1. G6P will decrease, and G6PD activity will increase.
2. G6P will increase, and G6PD activity will increase.
3. G6P will remain unchanged, and G6PD activity will decrease.
4. G6P will increase, and G6PD activity will decrease. (correct answer)

Explanation: When you encounter questions about metabolic inhibition, focus on understanding pathway interconnections and feedback mechanisms. The pentose phosphate pathway (PPP) consists of two key enzymes: glucose-6-phosphate dehydrogenase (G6PD) converts G6P to 6-phosphogluconolactone, and 6-phosphogluconate dehydrogenase converts 6-phosphogluconate to ribulose-5-phosphate while generating NADPH. During active fatty acid synthesis, cells have high NADPH demand. When 6-phosphogluconate dehydrogenase is inhibited, the PPP becomes backed up at the second step. This creates a bottleneck effect: 6-phosphogluconate accumulates because it cannot be converted further, which in turn slows the entire pathway. As flux through the PPP decreases, G6P accumulates because less is being consumed by the pathway, even though G6PD itself isn't directly inhibited. However, G6PD activity will decrease due to product inhibition - as downstream intermediates accumulate, they feedback inhibit earlier enzymes in the pathway. Option A is wrong because G6P increases rather than decreases when the pathway is blocked. Option B incorrectly suggests G6PD activity increases; while the cell needs more NADPH, the enzyme actually becomes less active due to pathway backup. Option C is incorrect because G6P concentration does change - it must increase when its primary consumption route (PPP) is impaired. Remember that non-competitive inhibition of any enzyme in a linear pathway creates upstream accumulation and downstream depletion. Always trace the metabolic consequences both directions from the inhibition site.

Question 4

1. Glucose-6-phosphate is diverted entirely into the PPP, and the resulting ribose-5-phosphate is then fully oxidized for ATP.
2. Glucose-6-phosphate enters the oxidative PPP for NADPH production, and the resulting carbon skeletons re-enter glycolysis to be metabolized for ATP generation. (correct answer)
3. The oxidative phase of the PPP is inhibited to maximize flux through glycolysis, with ATP production taking precedence over NADPH generation.
4. Glycolysis and the PPP operate in separate cellular compartments, preventing any interaction between their intermediates to ensure independent regulation.

Explanation: When both NADPH and ATP are required, the pathways are integrated. Glucose-6-phosphate first enters the oxidative phase of the PPP to produce NADPH. The resulting pentose phosphates are then converted by the non-oxidative phase back into glycolytic intermediates (fructose-6-phosphate and glyceraldehyde-3-phosphate). These intermediates can then proceed through the remainder of glycolysis and subsequent pathways to generate ATP.

Question 5

1. One molecule of glyceraldehyde-3-phosphate and one molecule of sedoheptulose-7-phosphate.
2. Three molecules of ribose-5-phosphate.
3. Two molecules of fructose-6-phosphate and one molecule of glyceraldehyde-3-phosphate. (correct answer)
4. One molecule of fructose-6-phosphate and three molecules of glyceraldehyde-3-phosphate.

Explanation: This question tests the stoichiometry of the non-oxidative phase. The total number of carbons from the three pentoses (2 xylulose-5-P + 1 ribose-5-P) is 5 + 5 + 5 = 15 carbons. These are rearranged by transketolase and transaldolase. The net products are two hexoses (fructose-6-P) and one triose (glyceraldehyde-3-P), which also total 15 carbons (6 + 6 + 3 = 15). This conversion allows pentoses to be channeled back into glycolysis.

Question 6

1. Overall glucose consumption increases by 40% with proportional increases in both glycolytic and pentose phosphate pathway flux
2. Glycolytic flux increases by 40% due to increased glucose-6-phosphate availability from enhanced pentose phosphate pathway activity
3. Both pathways increase proportionally because the compound enhances general glucose metabolism without pathway-specific effects
4. Pentose phosphate pathway flux increases while glycolytic flux decreases due to competition for glucose-6-phosphate substrate (correct answer)

Explanation: When you encounter questions about metabolic pathway interactions, focus on substrate competition and how changes in one pathway affect others through shared intermediates. Glucose-6-phosphate (G6P) sits at a critical metabolic branch point where it can enter either glycolysis (toward pyruvate) or the pentose phosphate pathway (PPP). When glucose-6-phosphate dehydrogenase (G6PD) activity increases by 40% while 6-phosphofructokinase (PFK) remains unchanged, more G6P gets pulled into the PPP. Since cells have a finite pool of G6P at any given time, increased PPP flux means less substrate remains available for glycolysis. This creates a substrate competition scenario where the enhanced PPP activity effectively "steals" substrate from the glycolytic pathway. Answer D correctly identifies this competitive relationship - PPP flux increases due to enhanced G6PD activity while glycolytic flux decreases because of reduced G6P availability. Answer A is wrong because the compound specifically affects G6PD, not glucose uptake or general metabolism, so overall glucose consumption wouldn't increase proportionally. Answer B incorrectly suggests that PPP activity somehow increases G6P availability for glycolysis, when actually the opposite occurs - PPP consumes G6P. Answer C misses the pathway-specific nature of the compound's effect and ignores the competitive relationship between these pathways. Remember that metabolic pathways often compete for shared substrates. When one pathway's activity increases significantly, consider how this affects substrate availability for competing pathways, especially at major branch points like G6P.

Question 7

1. A high ratio of NADP⁺ to NADPH
2. High concentrations of insulin
3. A low ratio of NADP⁺ to NADPH (correct answer)
4. High concentrations of glucose-6-phosphate

Explanation: Glucose-6-phosphate dehydrogenase (G6PD) is the committed step of the pentose phosphate pathway. Its activity is primarily regulated by the availability of its substrate NADP⁺. The enzyme is strongly inhibited by its product, NADPH. Therefore, a low ratio of NADP⁺ to NADPH (i.e., high levels of NADPH) signifies that the cell's need for reducing power is met, leading to product inhibition of G6PD and decreased pathway flux.

Question 8

1. The oxidative phase is highly active, and the non-oxidative phase converts ribose-5-phosphate back into glycolytic intermediates. (correct answer)
2. The non-oxidative phase operates in reverse, using glycolytic intermediates to generate ribose-5-phosphate, which then enters the oxidative phase.
3. Only the oxidative phase is active, leading to an accumulation of ribose-5-phosphate that allosterically inhibits glucose-6-phosphate dehydrogenase.
4. Both the oxidative and non-oxidative phases are bypassed, as NADPH is primarily generated by the malic enzyme to support lipid synthesis.

Explanation: When NADPH is needed but ribose-5-phosphate (R5P) is not, the cell runs the oxidative phase to produce NADPH and R5P. The non-oxidative phase then converts the excess R5P back into fructose-6-phosphate and glyceraldehyde-3-phosphate, which can re-enter glycolysis. This maximizes NADPH production from glucose-6-phosphate.

Question 9

1. Reduced glutathione (GSH) (correct answer)
2. FAD
3. NADH
4. 2,3-Bisphosphoglycerate

Explanation: G6PD deficiency impairs the production of NADPH, especially under oxidative stress. NADPH is the essential cofactor for glutathione reductase, an enzyme that reduces oxidized glutathione (GSSG) back to its active, reduced form (GSH). GSH is critical for detoxifying reactive oxygen species. Without sufficient NADPH, GSH cannot be regenerated, leading to oxidative damage and hemolysis in red blood cells.

Question 10

1. Increased conversion of ribose-5-phosphate to fructose-6-phosphate and other glycolytic intermediates.
2. Accumulation of pentose phosphates such as xylulose-5-phosphate and ribose-5-phosphate. (correct answer)
3. A rapid decrease in the cellular concentration of NADPH due to feedback inhibition of G6PD.
4. Overproduction of sedoheptulose-7-phosphate due to a compensatory increase in transaldolase activity.

Explanation: Transketolase is a key enzyme in the non-oxidative phase of the pentose phosphate pathway and requires TPP as a cofactor. It catalyzes the transfer of two-carbon units from substrates like xylulose-5-phosphate. A deficiency in TPP impairs transketolase activity, causing its substrates (pentose phosphates like xylulose-5-phosphate and ribose-5-phosphate) to accumulate because they cannot be converted into glycolytic intermediates.

Question 11

1. It provides the reducing power for the electron transport chain to generate a proton gradient for ATP synthesis.
2. It is used to reduce oxidized cofactors such as FAD to FADH₂ in central catabolic pathways like the citric acid cycle.
3. It serves as the primary electron donor in reductive biosynthetic pathways and for antioxidant defense systems. (correct answer)
4. It acts as a key allosteric activator of phosphofructokinase-1 to coordinate energy production with biosynthetic needs.

Explanation: A fundamental concept in metabolism is the division of labor between NADH and NADPH. NADH is primarily involved in catabolism, where it carries electrons from fuel oxidation to the electron transport chain for ATP production. In contrast, NADPH is the main electron donor for anabolism (reductive biosynthesis, such as fatty acid and steroid synthesis) and for regenerating reduced glutathione to combat oxidative stress.

Question 12

1. 6 NADPH
2. 2 NADPH
3. 12 NADPH (correct answer)
4. 24 NADPH

Explanation: This process requires cycling. For each molecule of glucose-6-phosphate (G6P) entering the oxidative phase, 2 NADPH and 1 CO₂ are produced. The resulting 5-carbon sugar is recycled via the non-oxidative phase back to G6P. The overall stoichiometry is that 6 G6P molecules are converted to 6 molecules of ribulose-5-phosphate, yielding 12 NADPH and 6 CO₂. The 6 molecules of ribulose-5-phosphate are then rearranged to regenerate 5 molecules of G6P. The net reaction is: 1 G6P + 12 NADP⁺ → 6 CO₂ + 12 NADPH + Pi.

Question 13

1. Skeletal muscle lacks the enzyme glucose-6-phosphate dehydrogenase, so it cannot initiate the pathway at all.
2. The liver uses the PPP to generate ribose-5-phosphate as a primary precursor for gluconeogenesis, a pathway absent in muscle.
3. Resting skeletal muscle primarily uses fatty acids for fuel, limiting the availability of glucose-6-phosphate for the pathway.
4. The liver has a high demand for NADPH for biosynthetic processes like fatty acid synthesis, whereas resting muscle does not. (correct answer)

Explanation: When you encounter questions about tissue-specific metabolic pathway activity, focus on each tissue's unique metabolic demands and functions. The pentose phosphate pathway (PPP) serves two main purposes: generating NADPH for biosynthetic reactions and producing ribose-5-phosphate for nucleotide synthesis. The liver is a metabolic powerhouse with extensive biosynthetic responsibilities, particularly fatty acid and cholesterol synthesis. These anabolic processes require massive amounts of NADPH as a reducing agent. Since the PPP is the primary source of cytosolic NADPH, hepatic cells maintain high PPP activity to meet this demand. In contrast, resting skeletal muscle is primarily catabolic, breaking down glucose and fatty acids for energy rather than synthesizing complex molecules, so it has minimal NADPH requirements. Looking at the incorrect options: Choice A is factually wrong—skeletal muscle does contain glucose-6-phosphate dehydrogenase, just at lower activity levels. Choice B misrepresents gluconeogenesis, which uses different precursors like lactate, amino acids, and glycerol, not ribose-5-phosphate. Additionally, muscle can perform gluconeogenesis under certain conditions. Choice C contains a grain of truth about muscle fuel preference, but glucose-6-phosphate availability isn't the limiting factor for PPP activity—it's the demand for NADPH that drives the pathway. Remember this pattern: when comparing metabolic pathway activity between tissues, always consider what each tissue's primary job is. Biosynthetically active tissues like liver, adipose, and mammary glands will have higher PPP activity due to their NADPH requirements for fatty acid synthesis.

Question 14

1. Insulin signaling leads to direct phosphorylation and inactivation of glucose-6-phosphate dehydrogenase to favor glycogen storage.
2. Insulin indirectly inhibits the PPP by promoting the breakdown of fatty acids, which lowers the overall cellular demand for NADPH.
3. Insulin upregulates the transcription of genes for G6PD and 6-phosphogluconate dehydrogenase to increase NADPH supply for anabolism. (correct answer)
4. Insulin directly binds to and allosterically activates transketolase, which pulls intermediates through the non-oxidative phase.

Explanation: Insulin is an anabolic hormone that signals a state of energy abundance. It promotes pathways like fatty acid synthesis, which require NADPH. In the longer term, insulin signaling leads to increased transcription of the genes encoding the key enzymes of the PPP, such as G6PD and 6-phosphogluconate dehydrogenase. This increases the total capacity of the pathway to produce NADPH to support insulin-stimulated biosynthesis.

Question 15

1. Glycolysis, by producing NADH for mitochondrial antioxidant enzymes.
2. Beta-oxidation of fatty acids, by producing acetyl-CoA that can be used to synthesize antioxidant molecules.
3. The citric acid cycle, by generating FADH₂ and NADH to power detoxification reactions.
4. The pentose phosphate pathway, by generating NADPH for glutathione reductase. (correct answer)

Explanation: When you encounter questions about oxidative stress and antioxidant defenses, focus on which reducing agents (NADH vs. NADPH) power different cellular processes, especially in specialized cells like red blood cells. Paraquat creates a cycle of oxidative damage by generating superoxide radicals through reaction with oxygen. To counteract this, cells need robust antioxidant systems. The most critical defense against oxidative stress is the glutathione system, where reduced glutathione (GSH) neutralizes reactive oxygen species and gets oxidized to GSSG in the process. To regenerate the protective GSH from GSSG, glutathione reductase requires NADPH as its reducing cofactor. The pentose phosphate pathway (PPP) is the primary source of NADPH in most cells, making option D correct. This is especially crucial in red blood cells, which lack mitochondria and rely heavily on the PPP for antioxidant protection. Option A is wrong because red blood cells lack mitochondria, so mitochondrial antioxidant enzymes aren't relevant here. Option B incorrectly suggests beta-oxidation, which also requires mitochondria that red blood cells don't possess, and acetyl-CoA isn't directly used for antioxidant molecule synthesis. Option C fails for the same reason - red blood cells have no citric acid cycle since they lack mitochondria, and even if they did, this pathway produces NADH, not the NADPH needed for glutathione reductase. Remember: NADPH powers biosynthesis and antioxidant defenses, while NADH primarily feeds into energy production. For oxidative stress questions, think NADPH and the pentose phosphate pathway.

Question 16

1. The pentose phosphate pathway flux increases 12-fold to compensate for both reduced enzyme activity and increased NADPH demand
2. The pentose phosphate pathway flux increases approximately 12-fold, but the cell cannot meet the full NADPH demand due to the enzyme bottleneck (correct answer)
3. The cell redirects glucose through glycolysis and activates alternative NADPH-producing pathways like the malate-pyruvate cycle
4. The pentose phosphate pathway shuts down completely, and the cell relies entirely on NADH from glycolysis for reductive biosynthesis

Explanation: With G6PD activity at 25% of normal and NADPH demand increased 3-fold, the cell would need 12-fold higher flux through the pentose phosphate pathway (3-fold demand ÷ 0.25 activity = 12-fold). However, G6PD is often rate-limiting, so the reduced enzyme activity creates a bottleneck that prevents the pathway from achieving this flux level. The cell will increase PPP activity as much as possible but cannot fully compensate. Choice A ignores the enzyme limitation. Choice C describes a real adaptation but underestimates the PPP's continued importance. Choice D is incorrect as NADH cannot substitute for NADPH in reductive biosynthesis.

Question 17

1. The cell must run the non-oxidative phase in reverse to convert excess ribose-5-phosphate back to glycolytic intermediates
2. The cell must activate alternative NADPH-producing pathways while running the non-oxidative phase in reverse to generate more ribose-5-phosphate
3. The cell must run both oxidative and non-oxidative phases simultaneously to generate additional NADPH while maintaining ribose-5-phosphate levels
4. The cell must increase oxidative phase flux by 2.5-fold and use the non-oxidative phase to convert excess ribose-5-phosphate to fructose-6-phosphate (correct answer)

Explanation: When you encounter pentose phosphate pathway questions involving stoichiometric mismatches, focus on the quantitative relationship between NADPH and ribose-5-phosphate production versus cellular demand. The oxidative phase produces NADPH and ribose-5-phosphate in a 2:1 ratio, but the cell needs them in a 5:1 ratio. This means the cell needs 2.5 times more NADPH relative to ribose-5-phosphate than the oxidative phase naturally provides. To meet the 5:1 demand, you must increase oxidative phase flux by 2.5-fold to generate sufficient NADPH. However, this overproduces ribose-5-phosphate by 2.5-fold as well. The non-oxidative phase can then convert this excess ribose-5-phosphate to fructose-6-phosphate, which feeds back into glycolysis. Option A incorrectly assumes the cell has excess ribose-5-phosphate initially, but the real issue is insufficient NADPH production. Option B suggests activating alternative NADPH pathways, but this unnecessarily complicates the solution when increasing pentose phosphate flux is more direct. Option C fails to address the quantitative mismatch—simply running both phases simultaneously doesn't solve the stoichiometric problem of needing 2.5 times more NADPH per ribose-5-phosphate unit. The correct answer is D because it addresses both the NADPH shortage (by increasing oxidative flux 2.5-fold) and manages the resulting ribose-5-phosphate excess (by converting it to fructose-6-phosphate). Remember: pentose phosphate pathway problems often test your ability to balance stoichiometric demands through coordinated regulation of both oxidative and non-oxidative phases.

Question 18

1. Increasing glucose-6-phosphate dehydrogenase expression to boost oxidative phase flux and ribose-5-phosphate production proportionally (correct answer)
2. Activating the ribose-5-phosphate isomerase and ribulose-5-phosphate epimerase to optimize pentose interconversions within existing pathway constraints
3. Upregulating glycolysis to provide more fructose-6-phosphate and glyceraldehyde-3-phosphate for alternative ribose-5-phosphate synthesis routes
4. Enhancing glucose uptake to overcome the metabolic bottleneck through increased substrate availability for all pentose phosphate pathway reactions

Explanation: Transketolase deficiency impairs the non-oxidative phase's ability to interconvert pentoses and recycle them back to glycolytic intermediates. This makes the pathway less flexible. The most direct compensation is to increase the oxidative phase flux through higher G6PD activity, producing more ribose-5-phosphate directly from glucose-6-phosphate. Choice B helps with pentose interconversions but doesn't address the transketolase bottleneck. Choice C is inefficient since the defective transketolase is needed to convert glycolytic intermediates to ribose-5-phosphate. Choice D doesn't specifically address the enzyme deficiency.

Question 19

1. Red blood cells cannot synthesize new glucose-6-phosphate dehydrogenase to replace the deficient enzyme, making the deficiency permanent and severe
2. Red blood cells rely entirely on the pentose phosphate pathway for ATP production, so G6PD deficiency causes energy failure during stress
3. Red blood cells cannot produce NADPH through alternative pathways and depend critically on the pentose phosphate pathway for glutathione-based antioxidant defense (correct answer)
4. Red blood cells have unusually high ribose-5-phosphate requirements for membrane repair, which cannot be met when the pentose phosphate pathway is impaired

Explanation: Red blood cells are unique because they lack mitochondria and most biosynthetic machinery, making them entirely dependent on the pentose phosphate pathway for NADPH production. NADPH is essential for maintaining glutathione in its reduced form, which is the primary antioxidant defense mechanism in RBCs. G6PD deficiency severely limits this capacity. Choice A is true but doesn't explain the oxidative stress connection. Choice B is incorrect - RBCs use glycolysis for ATP. Choice D is incorrect - RBCs have minimal nucleotide synthesis needs.

Question 20

1. Fatty acid synthesis inhibition reduces ATP demand, making glycolysis more favorable than the pentose phosphate pathway for energy production
2. Reduced fatty acid synthesis decreases NADPH consumption, leading to higher NADPH/NADP+ ratios that inhibit glucose-6-phosphate dehydrogenase (correct answer)
3. The fatty acid synthesis inhibitor directly blocks glucose-6-phosphate dehydrogenase activity, forcing glucose through glycolysis instead
4. Decreased fatty acid synthesis reduces acetyl-CoA levels, which normally activate the pentose phosphate pathway through allosteric regulation

Explanation: Fatty acid synthesis is a major consumer of NADPH. When this process is inhibited, NADPH consumption drops dramatically, causing the NADPH/NADP+ ratio to increase. High NADPH levels provide product inhibition of glucose-6-phosphate dehydrogenase, the rate-limiting enzyme of the pentose phosphate pathway. With less glucose flowing through the PPP, more is available for glycolysis. Choice A incorrectly suggests the PPP produces ATP. Choice C assumes direct enzyme inhibition without evidence. Choice D incorrectly describes acetyl-CoA as a PPP activator.